Abstract: The isolation and structural characterization of three new heterocyclic and macrocyclic peptides, balgacyclamides A-C, from Microcystis aeruginosa EAWAG 251 are reported. The constitutions were determined by 2D-NMR methods and mass spectrometry, and the configurations were assigned after ozonolysis and hydrolysis by HPLC-MS methods using Marfey's method as well as GC-MS using authentic standards. Balgacyclamides A and B were active against Plasmodium falciparum K1 in the low micromolar range, while displaying low toxicity to rat myoblasts. The isolation and structural characterization of three new heterocyclic and macrocyclic peptides, balgacyclamides A-C from Microcystis aeruginosa EAWAG 251 is reported. The constitution was determined by 2D-NMR methods and mass spectrometry and the configuration was assigned by HPLC-MS methods using Marfey's method as well as GC-MS using authentic standards. Balgacyclamides A and B were active against Plasmodium falciparum K1 in the low micromolar range, while displaying low toxicity to rat myoblasts.
INTRODUCTION
Cyclic peptides and derived macrocycles have recently received significant interest in a variety of fields, ranging from biosynthesis studies to drug discovery and development 1 , The potentially large, but structurally often well defined conformational space sampled, combined with the variety of amino acids renders peptides ideally suited to interact with many receptors or to interfere with protein/protein interactions. 1 Cyanobactins constitute a particular subset of cyclic peptides produced by cyanobacteria and can be defined as cyclic, ribosomally produced peptides (RiPP) 2 containing heterocyclic modifications. 3 They have been found not only in the producing organism, but also in other animals where they have been suggested to be of symbiotic or dietary origin. 4 A particular subset, the cyclamides are structurally well defined macrocyclic hexapeptides, where often hydrophobic residues flanked by heterocyclic rings such as oxazol(ine) or thiazol(ine) residues are observed. 5 While their biosynthesis has been investigated, 2-4,5m the bioactivity of these compounds both in their ecological niche as well as in a therapeutic setting has received much less attention. Early assumptions on the bioactivity suggested a role as allelochemicals, which has been supported by algicidal effects. 6 Another seemingly unrelated activity is related to multidrug-resistance reversing activity, which has been reported for several members of this family. 7 Most interestingly, Gerwick and coworkers reported significant antimalarial activity for the venturamides. 8 Independently, we have determined antimalarial activity for the aerucyclamides 9 that displayed improved activity when compared to the earlier study. 8 The best compound in this series, aerucyclamide B displayed antimalarial IC 50 of 0.7 μM against the Plasmodium falciparum K1 strain with a high selectivity over the L6 rat myoblasts cell line. Aerucyclamide B was taken up as a lead structure for a medicinal chemistry follow up program by Serra and coworkers that build on the first successful total synthesis of this compound. 10 Whereas these authors were able to briefly delineate a first structure activity relationship study, currently, the role of the different units on activity remained unclear. The current main hypothesis suggests that the degree of unsaturation of the heterocyclic rings is correlated with biological activitiy, [8] [9] [10] with higher unsaturation leading to more potent compounds. While this hypothesis is supported by several compounds (e.g. oxidation of an thiazoline to an thiazole in aerucyclamide A and B led to 10 times increased activity), more compounds are needed to corroborate these observations. In this study, we report on the isolation of new cyclamides from cyanobacteria, and evaluate the antimalarial properties in the P. falciparum K1 assay.
RESULTS AND DISCUSSION
The balgacyclamide were isolated from aqueous methanolic extracts of Microcystis aeruguinosa EAWAG 251 (identical to PCC 7820). These compounds were purified by a combination of C 18 -SPE, semi-preparative and analytical reverse phase HPLC methods. The structure determination proved to be challenging due to the low isolation yield of 0.37 mg, 0.10 mg, and 0.53 mg per 10 liters of culture, for the balgacyclamides A (1), B (2) and C (3) respectively. The sequence of the amino acids was challenging to determine because of the presence of resonance overlap in the 1 H and 13 The configuration of the balgacyclamides A-C (1-3) was determined with the same strategy as for the aerucyclamides. 9 First, the compounds were ozonized to avoid the epimerization of the Ile residues that are next to the thiazole residues, as it is known that amino acids next to thiazole or oxazole residues are prone to epimerization during hydrolysis. 13 The compounds were then hydrolyzed, and half the amount of the hydrolyzed compounds was derivatized with the Marfey's reagent 14 while the other half was derivatized with trifluoroacetic acid anhydride. In conclusion, we have reported the isolation and structure determination of the balgacyclamides A (1), B (2) and C (3) from Microcystis aeruguinosa EAWAG 251.
Balgacyclamides A (1) and B (2) were evaluated for their antiparasite activity and displayed micromolar IC 50 activity against P. falciparum with a good selectivity compared to their cytotoxicity.
EXPERIMENTAL SECTION
General Experimental Procedures. NMR spectra were acquired on a Bruker Avance 500, a Bruker DRX-600 and a Bruker Avance II 800, all equipped with cryoprobes. The spectra were referred to residual solvent proton and carbon signals (δ H 2.50, δ C 39.5 for DMSO-d 6 and δ H 7.26, δ C 77.2 for CDCl 3 ). Accurate mass ESI spectra were recorded on a Micromass (ESI) Q-TOF Ultima API. HPLC purification and analyses were performed on a Dionex HPLC system equipped with a P680 pump, an ASI-100 automated sample injector, a TCC-100 thermostated column compartment, a PDA-100 photodiode array detector, a Foxy Jr. fraction collector, and a MSQ-ESI mass spectrometric detector. The determination of the Ile enantiomers was carried out on a GC-FID instrument (Thermo Focus with a Thermo AS 3000 autosampler). Extraction and Isolation. The biomass was extracted first with 100% MeOH and then twice with 60% MeOH. The extract was separated from the biomass by centrifugation. MeOH was removed from the combined extracts by evaporation under reduced pressure and the mixture was then dried by lyophilization. The resulting powder was dissolved in 80% MeOH and centrifuged to remove remaining particles. The solutions were then sequentially loaded to a C 18 SPE column (Supelco Discovery DSC-18, 10 g, conditioned with 10% aqueous MeOH), and eluted with 30%, 60%, 80%, and 100% aqueous MeOH solutions. MeOH was removed from the combined extract by evaporation under reduced pressure and and the mixture was then dried by lyophilization. The resulting oil from the 80% MeOH fraction was redissolved in 80% MeOH, and the compounds were isolated using multiple C 18 RP-HPLC runs (Phenomenex Gemini C 18 (8.6, 3.7, 1.6) 5, 7, 8, 8', 9 4, 8, 8' 7 30.3, CH 1.95, m 5, 6, 8, 8' 8, 8' 8 17.8, CH3 0.67, d (6.9) 6, 7, 8' 8' 15.8, CH3 0.53, d (6.9) 6, 7, 8 NH (2) 2.86, dd (13.6, 6 .0) 5, 6, 8, 9/9' 5, 6, 8, 9/9' 8 135.4, qC 9/9' 129.0, CH 7.01, d (7.4) 7, 9/9', 11 3, 6, 7b, OH 10/10' 127.4, CH 6.94, dd (7.4, 7. Note the observed long-range J coupling between H-2 and H-6 in both balgacyclamides A (1) and B (2).
